✦ LIBER ✦

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

✍ Scribed by Michael Grövdal; Mohsen Karimi; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Mette S. Holm; Jon M. Tangen; Jonas Wallvik; Gunnar Öberg; Peter Hokland; Sten E. Jacobsen; Anna Porwit; Eva Hellström-Lindberg

Book ID: 108676826
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 498 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08235.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic relevance of achieving cytoge

Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy

✍ Sebastian Balleisen; Andrea Kuendgen; Barbara Hildebrandt; Rainer Haas; Ulrich G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Cytogenetic findings at diagnosis have influence on prognosis in patients with acute myelogenous leukaemia (AML) or MDS who undergo induction chemotherapy. Assessment of remission and treatment decisions are based on cytological findings. We analyzed the prognostic impact of cytogenetic remission st